Merck KGaA to Acquire Bio-Techne in $11.3B Life Science Deal
DARMSTADT, Germany & MINNEAPOLIS, June 25, 2026 Merck KGaA, Darmstadt, Germany has signed a definitive agreement to acquire Bio-Techne...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
DARMSTADT, Germany & MINNEAPOLIS, June 25, 2026 Merck KGaA, Darmstadt, Germany has signed a definitive agreement to acquire Bio-Techne...
MENLO PARK, Calif., June 10, 2026 Subtle Medical has received U.S. FDA clearance for SubtleHDâ„¢(CT), a new artificial intelligence-powered...
MILFORD, Massachusetts, USA – June 3, 2026 Waters Corporation has announced U.S. Food and Drug Administration (FDA) 510(k) clearance...
SAN DIEGO, Calif., June 3, 2026 Zepto Life Technology has achieved a significant regulatory milestone after receiving U.S. Food...
AUSTIN, Texas, May 26, 2026 TOBY, Inc., a biotechnology company focused on non-invasive disease detection technologies, has announced that...
ABBOTT PARK, Ill., May 27, 2026 Abbott has announced that the updated American Cancer Society (ACS) colorectal cancer screening...
BERLIN, Germany / WHIPPANY, N.J., May 7, 2026 Bayer announced positive topline results from the pivotal Phase III REVEAL...
Melbourne, Australia and Indianapolis, IN, United States – May 5, 2026 Telix Pharmaceuticals Limited has announced the publication of...
MILWAUKEE, Feb. 14, 2026 — New research presented at the AAAAI Annual Meeting 2026 demonstrates that machine learning (ML)...
LONDON, UK, Feb. 12, 2026 — Serac Healthcare announced that the U.S. Food and Drug Administration has granted Fast...
